Labshake search
Citations for Leinco Technologies :
1 - 16 of 16 citations for Triclosan 13C12 99% 100 Ug Ml In Mtbe 2 4 4 Trichloro 2 Hydroxydiphenyl Ether since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Immunology 2022Quote: ... and 100 μg anti CTLA-4 (clone 9D9, Leinco Technologies) in volume of 200 μg 1X PBS.
-
bioRxiv - Immunology 2023Quote: ... and treated with recombinant mouse IL-4 (Leinco technologies, Inc. I-207) at a 40ng/ml concentration for 6 hours ...
-
bioRxiv - Immunology 2022Quote: ... Mice were also treated with 4 μg mIFNβ neutralising antibodies (Leinco Technologies Inc). Control groups were treated with either buffer or an IgG isotype control antibody equivalently.
-
bioRxiv - Immunology 2023Quote: ... allowed to sit for 3 hours and treated with recombinant mouse IL-4 (Leinco technologies, Inc. I-207) for 4 hr ...
-
bioRxiv - Immunology 2020Quote: ... mice were treated with 2 mg of an Ifnar1-blocking antibody (MAR1-5A3, Leinco Technologies) by i.p ...
-
bioRxiv - Systems Biology 2021Quote: ... Recombinant purified N-terminal domain (NTD) of the SARS-CoV-2 was obtained from Leinco Technologies Inc (Cat #S853 ...
-
LSD1 inhibition improves efficacy of adoptive T cell therapy by enhancing CD8+ T cell responsivenessbioRxiv - Immunology 2023Quote: ... checkpoint blockade was performed by intraperitoneal injection of 200 ug anti-mouse PD-L1 (clone 10F.9G2, Leinco Technologies) or isotype control anti-rat IgG2gb ...
-
bioRxiv - Immunology 2023Quote: ... they were treated with anti-PD-1 anti-CTLA-4 antibodies (clones RMP1-14 and 9H10, respectively, from Leinco Technologies Inc., Fenton, MO, USA): 200 µg ab/injection ...
-
bioRxiv - Microbiology 2021Quote: ... Male and female mice (4-5 weeks old) were treated by intraperitoneal injection with 2 mg of an anti-mouse IFNAR1 blocking antibody (MAR1-5A3, from Leinco Technologies). The next day ...
-
bioRxiv - Immunology 2023Quote: ... Antibody levels specific to Delta variant RBD were assessed in mouse sera by direct ELISA: plates were coated with 1 μg/ml Delta variant RBD (#S951-100, Leinco Technologies, Inc.) or MT-001 diluted in PBS and incubated at 4°C overnight ...
-
bioRxiv - Genetics 2023Quote: ... Clone 2.4G2 (Cat C247 Leinco Technologies (1:100)).
-
bioRxiv - Cancer Biology 2020Quote: ... or with 100 μg/mouse anti-mouse-Pd-1 (Leinco Technologies, P372) one and six days post tumor injection ...
-
bioRxiv - Neuroscience 2021Quote: ... rat anti-CD11b (#C227, Clone M1/70, 1:100, Leinco Technologies, St. Louis, MO), and rat anti-CD45 (#550539 ...
-
bioRxiv - Neuroscience 2023Quote: ... The primary antibodies included rat anti-CD11b (#C227, Clone M1/70, 1:100, Leinco Technologies),rabbit anti-B2m (#ab75853 ...
-
bioRxiv - Cancer Biology 2020Quote: ... Tumor bearing C57BL/6J mice were treated with either 100 μg/mouse isotype control antibody (Leinco Technologies, R1367) or with 100 μg/mouse anti-mouse-Pd-1 (Leinco Technologies ...
-
bioRxiv - Immunology 2022Quote: ... Co-cultures were treated with 10 µg/ml of anti-Mouse IFNα and anti-Mouse IFNβ (Leinco Technologies) every 24 hours ...